This inventor holds 1 USPTO granted patent. Top assignee: Centro De Ingenieria Genetica Y Biotechnologia. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Innovations in Vaccine Development by Santiago Dueñas Carrera
Introduction
Santiago Dueñas Carrera is a notable inventor based in Havana, Cuba. He has made significant contributions to the field of vaccine development, particularly in relation to hepatitis C virus (HCV). His innovative work has the potential to impact medical and pharmaceutical practices significantly.
Latest Patents
Santiago holds a patent for a chimeric vaccine antigen against hepatitis C virus. This invention involves chimeric vaccine antigens that comprise selected regions of different antigens of HCV, arranged in a pre-determined order within a polypeptide. The chimeric antigens can also include artificially formed specific epitopes for auxiliary T helper lymphocytes. The resulting vaccine compositions are designed for use in medicine and the pharmaceutical industry, offering both prophylactic and therapeutic applications against HCV. These compositions generate a powerful, broad-spectrum immune response against various antigens of the virus, utilizing a minimal number of components. He has 1 patent to his name.
Career Highlights
Santiago is affiliated with the Centro de Ingeniería Genética y Biotecnología, where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and a focus on addressing critical health challenges.
Collaborations
Santiago collaborates with talented individuals such as Daylen Aguilar Noriega and Yalena Amador Cañizares, contributing to a dynamic research environment that fosters innovation.
Conclusion
Santiago Dueñas Carrera's contributions to vaccine development exemplify the importance of innovation in addressing global health issues. His work on chimeric vaccine antigens against hepatitis C virus showcases the potential for scientific advancements to improve medical outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile